Brian J. Caveney - Nov 5, 2021 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, President of Diagnostics
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Brian J. Caveney
Stock symbol
LH
Transactions as of
Nov 5, 2021
Transactions value $
-$247,081
Form type
4
Date filed
11/9/2021, 01:49 PM
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +2.01K +24.91% 10.1K Nov 5, 2021 Direct F1, F2
transaction LH Common Stock Tax liability -$247K -899 -8.92% $274.84 9.18K Nov 5, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -2.01K -22.07% $0.00 7.1K Nov 5, 2021 Common Stock 2.01K Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Amount includes 69.3574 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3 Stock withholding to satisfy tax withholding obligations.
F4 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 5, 2020.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.